ArticleCardiovascular drugs and therapy2026

Re: Effects of Dapagliflozin Combined with Sacubitril/Valsartan on Cardiac Electrophysiology and Quantitative Myocardial Motion Parameters in Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction.

Ying ZhaoPubMed ↗Publisher ↗

No numbers read from the abstract.